Combination of C-reactive Protein, Infliximab Trough Levels, and Stable but Not Transient Antibodies to Infliximab Are Associated With Loss of Response to Infliximab in Inflammatory Bowel Disease
- 浏览0
Journal of Crohn’s & colitis
525-531页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



